Targeting HIV in semen to shut down AIDS
Breaking up amyloid fibrils in semen makes cells less likely to be infected
![Microscope close-up.](/sites/g/files/oketem591/files/styles/3_2_480x320/public/media/images/article-research-microscope-01.jpg.webp?itok=w9HMzKam)
A paper published in the journal eLife describes a small molecule that disrupts amyloids in semen that promote HIV infection. This tweezer-shaped molecule, called CLR01, also attacks the virus itself.
CLR01 could also be useful for neurodegenerative disorders like Parkinson's disease.